EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 3.0

Death Receptors in the Selective Degeneration of Motoneurons in Amyotrophic Lateral Sclerosis

Julianne Aebischer, Nathalie Bernard-Marissal, Brigitte Pettmann iD, Cédric Raoul

Journal of Neurodegenerative Diseases · 2013

DOI: 10.1155/2013/746845 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Neurodegenerative Diseases, 2013. Verfasst von Julianne Aebischer und 3 weiteren Autor:innen. Beteiligte Einrichtung: Inserm-Avenir team, The Mediterranean Institute of Neurobiology (INMED), 13288 Marseille, France ; Neurodegenerative Studies Laboratory, Brain Mind I…. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 116 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0). Gefördert von: Institut National de la Santé et de la Recherche Médicale, Association Française contre les Myopathies, Association Française pour la Recherche sur la SLA.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

While studies on death receptors have long been restricted to immune cells, the last decade has provided a strong body of evidence for their implication in neuronal death and hence neurodegenerative disorders such as amyotrophic lateral sclerosis (ALS). ALS is a fatal paralytic disorder that primarily affects motoneurons in the brain and spinal cord. A neuroinflammatory process, associated with astrocyte and microglial activation as well as infiltration of immune cells, accompanies motoneuron degeneration and supports the contribution of non-cell-autonomous mechanisms in the disease. Hallmarks of Fas, TNFR, LT- β R, and p7 5 N T R signaling have been observed in both animal models and ALS patients. This review summarizes to date knowledge of the role of death receptors in ALS and the link existing between the selective loss of motoneurons and neuroinflammation. It further suggests how this recent evidence could be included in an ultimate multiapproach to treat patients.

Autor:innen und Institutionen

  • Inserm-Avenir team, The Mediterranean Institute of Neurobiology (INMED), 13288 Marseille, France ; Neurodegenerative Studies Laboratory, Brain Mind Institute, The Swiss Federal Institute of Technology Lausanne (EPFL), C…
  • Inserm-Avenir team, The Mediterranean Institute of Neurobiology (INMED), 13288 Marseille, France ; Department of Medical Genetics, University of Lausanne, CH-1005 Lausanne, Switzerland.
  • Inserm-Avenir team, The Mediterranean Institute of Neurobiology (INMED), 13288 Marseille, France ; The Mediterranean Institute of Neurobiology (INMED), Inserm UMR901, 13288 Marseille, France.
  • Inserm-Avenir team, The Mediterranean Institute of Neurobiology (INMED), 13288 Marseille, France ; The Neuroscience Institute Montpellier (INM), INSERM UMR1051, Saint Eloi Hospital, 34091 Montpellier, France.

ORCID-Profile: Brigitte Pettmann

Förderung

  • Institut National de la Santé et de la Recherche Médicale
  • Association Française contre les Myopathies
  • Association Française pour la Recherche sur la SLA
  • Direction de l’Hospitalisation et de l’Organisation des Soins
  • American ALS Association
  • PACA and LR Regional Council
  • Thierry Latran Foundation
  • LASCCO

Zitieren

APA

Aebischer, J., Bernard-Marissal, N., Pettmann, B., & Raoul, C. (2013). Death Receptors in the Selective Degeneration of Motoneurons in Amyotrophic Lateral Sclerosis. Journal of Neurodegenerative Diseases. https://doi.org/10.1155/2013/746845

Vancouver

Aebischer J, Bernard-Marissal N, Pettmann B, Raoul C. Death Receptors in the Selective Degeneration of Motoneurons in Amyotrophic Lateral Sclerosis. Journal of Neurodegenerative Diseases. 2013. doi:10.1155/2013/746845

BibTeX
@article{Aebischer2013,
  author = {Aebischer, Julianne and Bernard-Marissal, Nathalie and Pettmann, Brigitte and Raoul, Cédric},
  title = {Death Receptors in the Selective Degeneration of Motoneurons in Amyotrophic Lateral Sclerosis},
  journal = {Journal of Neurodegenerative Diseases},
  year = {2013},
  doi = {10.1155/2013/746845}
}
Kostenlos starten →